Impact investing arm of Bayer AG focused on breakthrough solutions in health and agriculture. Invests in companies developing cell and gene therapies, genomics, digital health, and sustainable agriculture.
€10M – €50M
Fund size: $1.4B+ committed through 2024
Learn more about Leaps by Bayer using AI:
Learn what Leaps by Bayer and similar investors look for:
Tips, programs, and cultural notes